XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.2

Segment Performance Measures and Expenses (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Significant Expense Categories and Consolidated Net Loss

The table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):

 Schedule of Significant Expense Categories and Consolidated Net Loss

		2025				2024
		For the six months ended June 30,
		(In thousands)								Change Increase (Decrease)
		2025				2024
Operating Expenses:
Clinical Research
OVATION		$	382			$	721			$	(339	)			(47.0	)%
Placcine Vaccine			33				889				(856	)			(96.3	)%
Other Clinical and Regulatory			951				1,100				(149	)			(13.5	)%
Subtotal			1,366				2,710				(1,344	)			(49.6	)%
Non-Clinical R&D and CMC
OVATION			1,485				652				833				127.8	%
PlaCCine Vaccine			-				1,956				(1,956	)			-	%
Manufacturing (CMC)			541				796				(255	)			(32.0	)%
Subtotal			2,026				3,404				(1,378	)			(40.5	)%
Research and development expenses			3,392				6,114				(2,722	)			(44.5	)%
General and administrative expenses			3,521				3,911				(390	)			(10.0	)%
Total operating expenses			6,913				10,025				(3,112	)			(31.0	)%
Loss from operations		$	(6,913	)		$	(10,025	)		$	(3,112	)			(31.0	)%

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration